Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Efficacy and Safety of Fremanezumab for the Preventive Treatment of Episodic Migraine in Children and Adolescents: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

              Author:Hershey, Andrew D.   Szperka, Christina L.   Barbanti, Piero   Pozo-Rosich, Patricia   Bittigau, Petra   Barash, Steve   Garnett, Sally   Bryson, Juline   Kessler, Yoel   Carmeli Schwartz, Yael   Ning, Xiaoping   

              Session Name:PL5: Clinical Trials Plenary Session  

              Topic:Headache  

              Program Number:PL5.001  

              Author Institution:Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA, Cincinnati, OH  Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA  Headache and Pain Unit, IRCCS San Raffaele, Rome, Italy, and San Raffaele University, Rome, Italy, Rome, Italy  Headache Unit and Research Group, Vall d’Hebron Hospital and Research Institute, Universitat Autonoma de Barcelona, Barcelona, Spain, Barcelona, Spain  Charité-Universitätsmedizin Berlin, Berlin, Germany, Berlin, Germany  Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA, West Chester, PA  Teva Pharmaceutical Industries Ltd., Tel Aviv, Israel, Tel Aviv, Israel